Source link : https://www.newshealth.biz/health-news/investigational-med-for-tourette-syndrome-promising/
PHILADELPHIA — The investigational agent ecopipam reduces tic severity in children and adolescents with Tourette syndrome (TS) without exacerbating common psychiatric comorbidities, results of a new analysis suggest. As previously reported, the first-in-class dopamine-1 (D1) receptor antagonist reduced the primary endpoint of tic severity scores by 30% compared with placebo among 149 patients in the […]
Author : News Health
Publish date : 2024-10-01 14:47:56
Copyright for syndicated content belongs to the linked Source.